This article is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Never start, stop, or change medication without consulting your prescribing physician.
UpOrbit has no financial relationship with any pharmaceutical company. No affiliate links on this page.
Why this is complicated
Cannabis is the most commonly used substance among adults with ADHD aside from caffeine and nicotine. A meta-analysis of long-term studies (Lee et al., 2011) found that children with ADHD were more likely than their peers to later develop abuse of or dependence on substances, including marijuana. Yet research on the specific interaction between cannabis and ADHD is remarkably sparse — partly because cannabis's legal status has historically made clinical trials difficult.
What follows is what the available evidence says. It's incomplete. It will evolve. Talk to your doctor about your specific situation.
What people report using it for
In surveys, adults with ADHD commonly report using cannabis for:
- Sleep — particularly difficulty "turning off" at night. See ADHD sleep problems.
- Anxiety reduction — calming racing thoughts
- "Slowing down" — reducing hyperactivity and restlessness
- Emotional regulation — managing frustration and irritability
Mitchell et al. (2016) analyzed online forum discussions about cannabis and ADHD and found that 25% of posts described cannabis as therapeutic for ADHD, compared with 8% describing it as harmful. However, self-reported benefit doesn't necessarily mean objective improvement — particularly because cannabis affects the subjective experience of time and attention in ways that can feel like improvement while measurably impairing performance.
What the science says so far
On attention and executive function: Cannabis impairs working memory, attention, and processing speed acutely (while intoxicated). Broyd et al. (2016) reviewed the neurocognitive effects and found that THC specifically impairs the exact executive functions that are already compromised in ADHD. The question is whether chronic, low-dose use has different effects — and we don't have good data yet.
On dopamine: This is where it gets neurochemically interesting. THC initially stimulates dopamine release. However, Bloomfield et al. (2016) found that chronic cannabis use is associated with reduced dopamine synthesis capacity in the striatum. For a brain that already has dopamine deficiency (the core ADHD neurochemical issue), chronic cannabis use could theoretically worsen baseline dopamine function over time.
On medication interaction: Cannabis use may blunt some medication benefits and complicates clinical assessment — it becomes harder for your prescriber to determine whether medication is working when cannabis is introducing its own neurochemical effects.
Cannabinoid trials: One small, randomized controlled trial by Cooper et al. (2017) tested Sativex (THC:CBD 1:1) for adult ADHD. It found no significant difference from placebo on its main outcome; a nominal improvement in hyperactivity/impulsivity did not hold up after correcting for multiple comparisons. Trials like this remain rare, and it used a THC-containing product, so it tells us little about CBD alone.
The risk picture
- Substance use vulnerability: ADHD independently increases risk for substance use disorders. Adding cannabis doesn't help this equation. Chang et al. (2014) showed that stimulant treatment actually reduces substance use risk in ADHD — the opposite direction from adding cannabis.
- Adolescent/young adult brain development: The strongest evidence for cannabis harm is in brains under 25, where it may affect prefrontal cortex development. Since ADHD already involves prefrontal differences, this population may be particularly vulnerable.
- Cannabis use disorder: ADHD increases the risk of progressing from use to problematic use. The impulsivity component of ADHD may make it harder to regulate consumption.
If you currently use cannabis and have ADHD
This article is not telling you to stop. That's between you and your healthcare provider. What the research suggests:
- Be honest with your prescriber. They need accurate information to manage your treatment. Many providers are pragmatic about cannabis use — they'd rather know than not know.
- If you're starting medication, consider reducing or stopping cannabis for 2–4 weeks during titration so you and your doctor can get a clean read on how the medication works. You can always resume later, but the titration period is a poor time for confounding variables.
- Track your patterns. If you use cannabis, notice whether it actually helps specific symptoms or whether you're self-medicating discomfort that could be addressed through treatment adjustment. UpOrbit's tracking can help document patterns.
References
- Lee et al. (2011). Prospective association of childhood ADHD and substance use and abuse/dependence: a meta-analytic review. Clinical Psychology Review, 31(3), 328-341.
- Mitchell et al. (2016). "I use weed for my ADHD": a qualitative analysis of online forum discussions on cannabis use and ADHD. PLoS One, 11(5), e0156614.
- Broyd et al. (2016). Acute and chronic effects of cannabinoids on human cognition: a systematic review. Biological Psychiatry, 79(7), 557-567.
- Bloomfield et al. (2016). The effects of Δ9-tetrahydrocannabinol on the dopamine system. Nature, 539(7629), 369-377.
- Cooper et al. (2017). Cannabinoids in attention-deficit/hyperactivity disorder: a randomised-controlled trial. European Neuropsychopharmacology, 27(8), 795-808.